Drug Type CAR-M |
Synonyms TGFbR2 CAR-M(Carisma) |
Target |
Mechanism TGFBR2 inhibitors(Transforming growth factor beta receptor 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Fibrosis | Preclinical | US | 07 May 2024 |